Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Luxembourg Industries, often referred to as Luxembourg-Pamol, is a specialty chemical manufacturer that provides high-purity intermediates and reagents for the pharmaceutical, agrochemical, and life science industries. Headquartered in Israel with a significant presence in the United States through Luxembourg-Pamol, Inc., the company is a global leader in the production of complex chemicals, including phosphorus-based compounds and bromine derivatives. The company is particularly well-regarded in the biotechnology sector for its specialized reagents used in peptide synthesis, such as coupling agents and protecting groups. By serving as a reliable supplier of critical chemical building blocks, Luxembourg-Pamol plays an essential role in the global pharmaceutical supply chain and the development of novel therapeutic agents. The company operates state-of-the-art manufacturing facilities that comply with rigorous international quality and environmental standards.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Luxembourg-Pamol.